Blood eosinophils in COPD: friend or foe?

References

• Mathers CD, Loncar D, . Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006 Nov;3(11):e442.
   PubMed Web of Science ®Google Scholar
• Global Strategy for the Diagnosis, Management, and Prevention of COPD, GOLD 2021.
   Google Scholar
• Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016 Jul;138(1):16–27.
   PubMed Web of Science ®Google Scholar
• Rutgers SR, Timens W, Kaufmann HF, et al. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J. 2000 Jan;15(1):109–115.
   PubMed Web of Science ®Google Scholar
• Hastie AT, Martinez FJ, Curtis JL, et al. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017 Dec 5;5(12):956–967.
   PubMed Web of Science ®Google Scholar
• Bafadhel M, Criner G, Dransfield MT, et al. Exacerbations of chronic obstructive pulmonary disease: time to rename. Lancet Respir Med. 2020 Feb;8(2):133–135.
   PubMed Web of Science ®Google Scholar
• Papaioannou AI, Loukides S, Bakakos P, et al. Dual bronchodilator in the era of triple therapy. Int J Chron Obstruct Pulmon Dis. 2020;15:2695–2705.
   PubMed Web of Science ®Google Scholar
• Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol. 2000 Apr;105(4):651–663.
   PubMed Web of Science ®Google Scholar
• Tavernier J, Van der Heyden J, Verhee A, et al. Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit. Blood. 2000 Mar 1;95(5):1600–1607.
   PubMed Web of Science ®Google Scholar
• Shamri R, Xenakis JJ, Spencer LA. Eosinophils in innate immunity: an evolving story. Cell Tissue Res. 2011 Jan;343(1):57–83.
   PubMed Web of Science ®Google Scholar
• Hallstrand TS, Henderson WR Jr. An update on the role of leukotrienes in asthma. Curr Opin Allergy Clin Immunol. 2010 Feb;10(1):60–66.
   PubMed Web of Science ®Google Scholar
• Spry CJF. The natural history of eosinophils. the immunopharmacology of eosinophils. London: Academic Press; 1993.
   Google Scholar
• George L, Brightling CE. Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease. Ther Adv Chronic Dis. 2016 Jan;7(1):34–51.
   PubMed Web of Science ®Google Scholar
• Jacobsen EA, Helmers RA, Lee JJ, et al. The expanding role(s) of eosinophils in health and disease. Blood. 2012 Nov8;120(19):3882–3890.
   PubMed Web of Science ®Google Scholar
• MacDonald AS, Araujo MI, Pearce EJ. Immunology of parasitic helminth infections. Infect Immun. 2002 Feb;70(2):427–433.
   PubMed Web of Science ®Google Scholar
• Torrent M, Navarro S, Moussaoui M, et al. Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans. Biochemistry. 2008 Mar 18;47(11):3544–3555.
   PubMed Web of Science ®Google Scholar
• Rosenberg HF, Dyer KD, Domachowske JB. Respiratory viruses and eosinophils: exploring the connections. Antiviral Res. 2009 Jul;83(1):1–9.
   PubMed Web of Science ®Google Scholar
• Handzel ZT, Busse WW, Sedgwick JB, et al. Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol. 1998 Feb 1;160(3):1279–1284.
   PubMed Web of Science ®Google Scholar
• Rosenberg HF, Dyer KD, Foster PS. Eosinophils: changing perspectives in health and disease. Nat Rev Immunol. 2013 Jan;13(1):9–22.
   PubMed Web of Science ®Google Scholar
• Mesnil C, Raulier S, Paulissen G, et al. Lung-resident eosinophils represent a distinct regulatory eosinophil subset. J Clin Invest. 2016 Sep 1;126(9):3279–3295.
   PubMed Web of Science ®Google Scholar
• Giembycz MA, Lindsay MA. Pharmacology of the eosinophil. Pharmacol Rev. 1999 Jun;51(2):213–340.
   PubMed Web of Science ®Google Scholar
• McBrien CN, Menzies-Gow A. The biology of eosinophils and their role in Asthma. Front Med (Lausanne). 2017;4:93.
   PubMed Web of Science ®Google Scholar
• Wong CK, Cheung PF, Ip WK, et al. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol. 2007 Jul;37(1):85–96.
   PubMed Web of Science ®Google Scholar
• Muraki M, Gleich GJ, Kita H. Antigen-specific IgG and IgA, but not IgE, activate the effector functions of eosinophils in the presence of antigen. Int Arch Allergy Immunol. 2011;154(2):119–127.
   PubMed Web of Science ®Google Scholar
• Winkel P, Statland BE, Saunders AM, et al. Within-day physiologic variation of leukocyte types in healthy subjects as assayed by two automated leukocyte differential analyzers. Am J Clin Pathol. 1981 May;75(5):693–700.
   PubMed Web of Science ®Google Scholar
• Balbi B, Pignatti P, Corradi M, et al. Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults. Eur Respir J. 2007 Oct;30(4):769–781.
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Wechsler ME. Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2018;13:335–349.
   PubMed Web of Science ®Google Scholar
• Brightling CE, McKenna, S, Hargadon, B, et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax. 2005 Mar;60(3):193–198.
   PubMed Web of Science ®Google Scholar
• Oliver B, Tonga K, Darley D, et al. COPD treatment choices based on blood eosinophils: are we there yet? Breathe (Sheff). 2019 Dec;15(4):318–323.
   PubMedGoogle Scholar
• Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2000 Oct 28;356(9240):1480–1485.
   PubMed Web of Science ®Google Scholar
• Leigh R, Pizzichini MM, Morris MM, et al. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J. 2006 May;27(5):964–971.
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2012 Jul 1;186(1):48–55.
   PubMed Web of Science ®Google Scholar
• Hospers JJ, Schouten JP, Weiss ST, et al. Eosinophilia is associated with increased all-cause mortality after a follow-up of 30 years in a general population sample. Epidemiology. 2000 May;11(3):261–268.
   PubMed Web of Science ®Google Scholar
• Vedel-Krogh S, Nielsen SF, Lange P, et al. Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. the copenhagen general population study. Am J Respir Crit Care Med. 2016 May 1;193(9):965–974.
   PubMed Web of Science ®Google Scholar
• Pascoe S, Barnes N, Brusselle G, et al. Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial. Lancet Respir Med. 2019 Sep;7(9):745–756.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Martinez FJ, Ferguson GT, et al. Triple inhaled therapy at two glucocorticoid doses in moderate-to-Very-Severe COPD. N Engl J Med. 2020 Jul 2;383(1):35–48.
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Dransfield MT, Han MK, et al. The effect of exacerbation history on outcomes in the IMPACT trial. Eur Respir J. 2020;55(5):May.
   Web of Science ®Google Scholar
• Mathioudakis AG, Bikov A, Foden P, et al. Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD. Eur Respir J. 2020;55(5):May.
   Web of Science ®Google Scholar
• Chalmers JD, Laska IF, Franssen FME, et al. Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline. Eur Respir J. 2020 Jun;55(6):2000351.
   PubMed Web of Science ®Google Scholar
• Harries TH, Rowland V, Corrigan CJ, et al. Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis. Respir Res. 2020 Jan 3;21(1):3.
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010 Sep 16;363(12):1128–1138.
   PubMed Web of Science ®Google Scholar
• Singh D, Kolsum U, Brightling CE, et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014 Dec;44(6):1697–1700.
   PubMed Web of Science ®Google Scholar
• Negewo NA, McDonald VM, Baines KJ, et al. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1495–1504.
   PubMed Web of Science ®Google Scholar
• Proboszcz M, Mycroft K, Paplinska-Goryca M, et al. Relationship between blood and induced sputum eosinophils, bronchial hyperresponsiveness and reversibility of airway obstruction in mild-to-moderate chronic obstructive pulmonary disease. COPD. 2019 Dec;16(5–6):354–361.
   PubMedGoogle Scholar
• Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011 Sep 15;184(6):662–671.
   PubMed Web of Science ®Google Scholar
• Soter S, Barta I, Antus B. Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide. Inflammation. 2013 Oct;36(5):1178–1185.
   PubMed Web of Science ®Google Scholar
• Bafadhel M, Davies L, Calverley PM, et al. Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis. Eur Respir J. 2014 Sep;44(3):789–791.
   PubMed Web of Science ®Google Scholar
• Sivapalan P, Lapperre TS, Janner J, et al. Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial. Lancet Respir Med. 2019 Aug;7(8):699–709.
   PubMed Web of Science ®Google Scholar
• Greulich T, Tuffers J, Mager S, et al. High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients - a retrospective analysis. Respir Res. 2020 May 6;21(1):106.
   PubMed Web of Science ®Google Scholar
• You Y, Shi GC. Blood eosinophils and clinical outcome of acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respiration. 2020 Dec;29:1–10.
   Google Scholar
• Couillard S, Larivee P, Courteau J, et al. Eosinophils in COPD exacerbations are associated with increased readmissions. Chest. 2017 Feb;151(2):366–373.
   PubMed Web of Science ®Google Scholar
• Bafadhel M, Greening NJ, Harvey-Dunstan TC, et al. Blood eosinophils and outcomes in severe hospitalized exacerbations of COPD. Chest. 2016 Aug;150(2):320–328.
   PubMed Web of Science ®Google Scholar
• Holland M, Alkhalil M, Chandromouli S, et al. Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease. Respirology. 2010 Jan;15(1):165–167.
   PubMed Web of Science ®Google Scholar
• Hegewald MJ, Horne BD, Trudo F, et al. Blood eosinophil count and hospital readmission in patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:2629–2641.
   PubMed Web of Science ®Google Scholar
• Jabarkhil A, Moberg M, Janner J, et al. Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis. Eur Clin Respir J. 2020;7(1):1757274.
   PubMed Web of Science ®Google Scholar
• Choi J, Oh JY, Lee YS, et al. The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019;14:953–959.
   PubMed Web of Science ®Google Scholar
• MacDonald MI, Osadnik CR, Bulfin L, et al. Low and high blood eosinophil counts as biomarkers in hospitalized acute exacerbations of COPD. Chest. 2019 Jul;156(1):92–100.
   PubMed Web of Science ®Google Scholar
• Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012 Nov;67(11):970–976.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Chanez P, Criner GJ, et al. Mepolizumab for eosinophilic chronic obstructive pulmonary disease. N Engl J Med. 2017 Oct 26;377(17):1613–1629.
   PubMed Web of Science ®Google Scholar
• Criner GJ, Celli BR, Brightling CE, et al. Benralizumab for the prevention of COPD exacerbations. N Engl J Med. 2019 Sep 12;381(11):1023–1034.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov Identifier: NCT04456673 & ClinicalTrials.gov Identifier: NCT03930732
   Google Scholar
• ClinicalTrials.gov Identifier: NCT02546700
   Google Scholar